Cargando...

Ketanserin in combination with beta-adrenergic receptor blocking agents in the treatment of essential hypertension.

The antihypertensive properties of ketanserin, a 5-HT2 receptor antagonist, was investigated in combination with beta-adrenoceptor blockade. Ketanserin was given 40 mg twice daily to 10 hypertensive patients during 4 weeks in a double-blind placebo-controlled trial. Ketanserin significantly reduced...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hedner, T, Persson, B
Formato: Artigo
Lenguaje:Inglês
Publicado: 1984
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1463538/
https://ncbi.nlm.nih.gov/pubmed/6150724
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!